SCHEMBL10565642

SCHEMBL10565642

COc1ccc(-c2cn(C)c(=O)n(C)c2=S)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ ERN1 O75460 1/20 0.44
▸ BRD4 O60885 6/20 0.44
▸ BRD9 Q9H8M2 4/20 0.44
▸ TDP2 O95551 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ GAA P10253 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10566304 0.85 ERN1 (0.59) PRKCAGSK3BERN1BRD4BRD9
SCHEMBL10565550 0.76 KIT (0.44) TDP2NPC1L3MBTL1GAAALDH1A1
SCHEMBL11434073 0.72 L3MBTL1 (0.47) PRKCAGSK3BBRD4BRD9NPC1
Formaldehyde SCHEMBL27945893 0.71 ERN1 (0.59) ERN1BRD4BRD9GAAALDH1A1
SCHEMBL10567603 0.71 KDM4E (0.42) BRD9TDP2NPC1L3MBTL1GAA
SCHEMBL22289953 0.70 BRD4 (0.59) PRKCAGSK3BBRD4BRD9
SCHEMBL10568294 0.67 TSHR (0.50) TDP2L3MBTL1GAAALDH1A1TSHR
SCHEMBL11434447 0.67 GAK (0.48) PRKCAGSK3BNPC1L3MBTL1GAA
SCHEMBL10732075 0.67 THRB (0.44) TDP2ALDH1A1TSHRHTTHSD17B10
SCHEMBL28705161 0.66 MAPT (0.50) NPC1L3MBTL1ALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback